首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Cephalosporin-induced alteration in hepatic glutathione redox state. A potential mechanism for inhibition of hepatic reduction of vitamin K123-epoxide in the rat.
【2h】

Cephalosporin-induced alteration in hepatic glutathione redox state. A potential mechanism for inhibition of hepatic reduction of vitamin K123-epoxide in the rat.

机译:头孢菌素诱导的肝谷胱甘肽氧化还原状态改变。抑制大鼠肝脏中维生素K123-环氧化物还原的潜在机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypoprothrombinemia is a serious adverse effect of antimicrobial therapy that occurs after administration of some second- and third-generation cephalosporins which contain the methyltetrazole-thiol (MTT) group. Previous studies have shown that in vitro MTT directly inhibits microsomal gamma-carboxylation of a synthetic pentapeptide. Since MTT is a thiocarbamide, a type of compound that can increase oxidation of glutathione, the present studies were carried out to determine whether alterations in hepatic glutathione redox state might interfere with vitamin K metabolism. Dose-related increases in biliary efflux and hepatic concentration of oxidized glutathione (GSSG) occurred after intravenous administration of MTT or MTT-containing antibiotics to rats. This finding suggested that these compounds could alter the hepatic glutathione redox state in vivo. Microsomal reduction of vitamin K epoxide occurred in the presence of 100 microM dithiothreitol (DTT), but was inhibited by preincubation with GSSG at concentrations as low as 10 microM. At higher concentrations of DTT (1.0 mM) inhibition by GSSG persisted, but higher concentrations were required, suggesting that the thiol/disulfide ratio, rather than the absolute concentration of GSSG was important. By contrast, GSSG did not effect microsomal gamma-carboxylation of a pentapeptide, using either vitamin K1 or its hydroquinone as a cofactor. These findings suggest a novel mechanism for the hypoprothrombinemia occurring after administration of MTT-containing antibiotics.
机译:凝血酶原降低症是抗生素治疗的严重不良反应,这种不良反应是在服用一些含有甲基四唑-硫醇(MTT)基团的第二代和第三代头孢菌素后发生的。先前的研究表明,体外MTT直接抑制合成五肽的微粒体γ-羧化作用。由于MTT是一种硫脲,一种可以增加谷胱甘肽氧化的化合物,因此,本研究旨在确定肝谷胱甘肽氧化还原状态的改变是否会干扰维生素K的代谢。向大鼠静脉内施用MTT或含MTT的抗生素后,胆汁外排量和肝中氧化型谷胱甘肽(GSSG)的剂量相关增加。这一发现表明这些化合物可以在体内改变肝谷胱甘肽的氧化还原状态。在存在100 microM二硫苏糖醇(DTT)的情况下发生了维生素K环氧化物的微粒体减少,但通过与浓度低至10 microM的GSSG预孵育而被抑制。在较高的DTT(1.0 mM)浓度下,GSSG的抑制作用持续存在,但需要较高的浓度,这表明硫醇/二硫比而不是GSSG的绝对浓度很重要。相反,使用维生素K1或其对苯二酚作为辅因子,GSSG不会影响五肽的微粒体γ-羧化。这些发现提示了在给予含MTT的抗生素后发生凝血酶原低血症的新机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号